Scientists from Nanyang Technological University Singapore (NTU Singapore) have developed an orally taken compound that reduces the amount of dietary fat absorbed in the intestines, offering an alternative approach to weight management.

• Mechanism: The compound acts directly in the gut to reduce fat absorption, distinct from weight-loss drugs that primarily suppress appetite or change glucose regulation.
• Collaboration: Research is being advanced with longevity biomedical firm Aria Bioscience Pte Ltd for potential consumer healthcare products and therapeutic uses.
• Potential impact: When combined with lifestyle and dietary interventions, the discovery could aid weight management and support efforts to tackle fatty liver disease.

This summary is based on a LinkedIn announcement by NTU Singapore.